Abstract
Aim:
To investigate the effect of gossypol on the growth of cultured human uterine leiomyoma and myometrial cells, the level of Bcl-2 and the activity of Src and estrogen receptor (ERα).
Methods:
Human uterine leiomyoma and adjacent normal myometrial cells were cultured in vitro. Both cell types were treated with a graded concentration of gossypol. Cell viability was assayed using CCK-8. Morphological change was observed with optical and electronic microscopy. Apoptosis was evaluated using TUNEL assay. Levels of Bcl-2, ERα and Src were analyzed using Western blotting.
Results:
Gossypol significantly inhibited growth and promoted apoptosis in cultured human uterine leiomyoma cells with the IC50 value and its corresponding 95% confidence intervals (CI) of 6.5 (4.0–10.5), 9.0 (4.9–16.5), and 7.5 (4.0–14.1) μmol/L at 20, 40, and 60 h, respectively. Gossypol exerted inhibitory effects on the myometrial cells with the IC50 value and its 95% CI of 49.1 (28.3–85.0), 14.5 (7.7–27.4), and 2.6 (1.2–5.6) μmol/L at 20, 40, and 60 h, respectively. Compared with control, gossypol 0.1-3.0 μmol/L markedly decreased the protein expression of Bcl-2 (P<0.05) in both leiomyoma and myometrial cells in a concentration-dependent manner, and significantly suppressed the level of phospho-Tyr416Src (P<0.05) in both cell types at 3.0 μmol/L without obvious alteration of c-Src and phospho-Tyr527Src levels (P>0.05). In addition, gossypol markedly reduced both the expression of ERα (P<0.05) at the low concentration of 0.1 μmol/L in the myometrial cells and the level of phospho-ser167ERα (P<0.05) at the high concentration of 3.0 μmol/L in the leiomyoma cells.
Conclusion:
Gossypol inhibits proliferation and induces apoptosis in human uterine leiomyoma and myometrial cells. It is likely that the mechanisms of action involve reducing the protein level of Bcl-2 and the activity of Src and ERα.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Walker CL . Role of hormonal and reproductive factors in the etiology and treatment of uterine leiomyoma. Recent Prog Horm Res 2002; 57: 277–94.
Walker CL, Stewart EA . Uterine fibroids: the elephant in the room. Science 2005; 308: 1589–92.
Wu X, Blanck A, Olovsson M, Henriksen R, Lindblom B . Expression of Bcl-2, Bcl-x, Mcl-1, Bax, and Bak in human uterine leiomyomas and myometrium during the menstrual cycle and after menopause. J Steroid Biochem Mol Biol 2002; 80: 77–83.
Kovács KA, Lengyel F, Környei JL, Vértes Z, Szabó I, Sümegi B, et al. Differential expression of Akt/protein kinase B, Bcl-2 and Bax proteins in human leiomyoma and myometrium. J Steroid Biochem Mol Biol 2003; 87: 233–40.
Perillo B, Sasso A, Abbondanza C, Palumbo G . 17Beta-estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence. Mol Cell Biol 2000; 20: 2890–901.
Gohel A, McCarthy MB, Gronowicz G . Estrogen prevents glucocorticoid-induced apoptosis in osteoblasts in vivo and in vitro. Endocrinology 1999; 140: 5339–47.
Lim KB, Ng CY, Ong CK, Ong CS, Tran E, Nguyen TT, et al. Induction of apoptosis in mammary gland by a pure anti-estrogen ICI 182780. Breast Cancer Res Treat 2001; 68: 127–38.
Schlessinger J . New roles for Src kinases in control of cell survival and angiogenesis. Cell 2000; 100: 293–6.
Johnson D, Agochiya M, Samejima K, Earnshaw W, Frame M, Wyke J . Regulation of both apoptosis and cell survival by the v-Src oncoprotein. Cell Death Differ 2000; 7: 685–96.
Chu I, Arnaout A, Loiseau S, Sun J, Seth A, McMahon C, et al. Src promotes estrogen-dependent estrogen receptor alpha proteolysis in human breast cancer. J Clin Invest 2007; 117: 2205–15.
Irby RB, Yeatman TJ . Role of Src expression and activation in human cancer. Oncogene 2000; 19: 5636–42.
Wiener JR, Windham TC, Estrella VC, Parikh NU, Thall PF, Deavers MT, et al. Activated SRC protein tyrosine kinase is overexpressed in late-stage human ovarian cancers. Gynecol Oncol 2003; 88: 73–9.
Zhu Y, Qiu XY, Wang L, Wu JH, Liu GM, He GL, et al. Effects of gestrinone on uterine leiomyoma and expression of c-Src in a guinea pig model. Acta Pharmacol Sin 2007; 28: 685–94.
Liu GZ . Clinical study of gossypol as a male contraceptive. Reproduccion 1981; 5: 189–93.
Wu D . An overview of the clinical pharmacology and therapeutic potential of gossypol as a male contraceptive agent and in gynaecological disease. Drugs 1989; 38: 333–41.
Moon DO, Kim MO, Lee JD, Kim GY . Gossypol suppresses NF-κB activity and NF-κB-related gene expression in human leukemia U937 cells. Cancer Lett 2008; 264: 192–200.
Zhang M, Liu H, Tian Z, Griffith BN, Ji M, Li QQ . Gossypol induces apoptosis in human PC-3 prostate cancer cells by modulating caspase-dependent and caspase-independent cell death pathways. Life Sci 2007; 80: 767–74.
Macoska JA, Adsule S, Tantivejkul K, Wang S, Pienta KJ, Lee CT . (−)Gossypol promotes the apoptosis of bladder cancer cells in vitro. Pharmacol Res 2008; 58: 323–31.
Xu, L, Yang D, Wang S, Tang W, Liu M, Davis M, et al. (−)-Gossypol enhances response to radiation therapy and results in tumor regression of human prostate cancer. Mol Cancer Ther 2005; 4: 197–205.
Jiang J, Kulp SK, Sugimoto Y, Liu S, Lin YC . The effects of gossypol on the invasiveness of MAT-LyLu cells and MAT-LyLu cells from the metastasized lungs of MAT-LyLu-bearing Copenhagen rats. Anticancer Res 2000; 20: 4591–7.
Zhang Y, Wang Y, Li C, Zhou J, Zhang D, Han M . Estrogen and progestin cytosol receptor concentrations in patients with endometriosis and their changes after gossypol therapy. Chin Med J 1996; 109: 814–6.
Han ML, Wang YF, Tang MY, Ge QS, Zhou LF, Zhu PD, et al. Gossypol in the treatment of endometriosis and uterine myoma. Contrib Gynecol Obstet 1987; 16: 268–70.
Zhang M, Liu H, Guo R, Ling Y, Wu X, Li B, et al. Molecular mechanism of gossypol-induced cell growth inhibition and cell death of HT-29 human colon carcinoma cells. Biochem Pharmacol 2003; 66: 93–103.
Teng CS . c-fos protein expression in apoptotic rat spermatocytes induced by gossypol. Contraception 1998; 57: 281–6.
Maruo T, Ohara N, Wang J, Matsuo H . Sex steroidal regulation of uterine leiomyoma growth and apoptosis. Hum Reprod Update 2004; 10: 207–20.
Oliver CL, Miranda MB, Shangary S, Land S, Wang S, Johnson DE . (−)-Gossypol acts directly on the mitochondria to overcome Bcl-2- and Bcl-XL-mediated apoptosis resistance. Mol Cancer Ther 2005; 4: 23–31.
Iravani S, Zhang HQ, Yuan ZQ, Cheng JQ, Karl RC, Jove R, Coppola D . Modification of insulin-like growth factor 1 receptor, c-Src, and Bcl-XL protein expression during the progression of Barrett's neoplasia. Hum Pathol 2003; 34: 975–82.
Karni R, Jove R, Levitzki A . Inhibition of pp60c-Src reduces Bcl-XL expression and reverses the transformed phenotype of cells overexpressing EGF and HER-2 receptors. Oncogene 1999; 18: 4654–62.
Dai Y, Rahmani M, Corey SJ, Dent P, Grant S . A Bcr/Abl-independent, Lyn-dependent form of imatinib mesylate (STI-571) resistance is associated with altered expression of Bcl-2. J Biol Chem 2004; 279: 34227–39.
Jia HY, Wu JX, Zhu XF, Chen JM, Yang SP, Yan HJ, et al. ZD6474 inhibits Src kinase leading to apoptosis of imatinib-resistant K562 cells. Leuk Res 2009; 33: 1512–9.
Ohigashi T, Ueno M, Nonaka S, Nakanoma T, Furukawa Y, Deguchi N, et al. Tyrosine kinase inhibitors reduce bcl-2 expression and induce apoptosis in androgen-dependent cells. Am J Physiol Cell Physiol 2000; 278: C66–72.
Lee M, Kim JY, Koh WS . Apoptotic effect of PP2 a Src tyrosine kinase inhibitor, in murine B cell leukemia. J Cell Biochem 2004; 93: 629–38.
Boulet I, Fagard R, Fischer S . Correlation between phosphorylation and kinase activity of a tyrosine protein kinase: p56lck. Biochem Biophys Res Commun 1987; 149: 56–64.
Thomas JE, Soriano P, Brugge JS . Phosphorylation of c-Src on tyrosine 527 by another protein tyrosine kinase. Science 1991; 254: 568–71.
Jakimiuk AJ, Bogusiewicz M, Tarkowski R, Dziduch P, Adamiak A, Wróbel A, et al. Estrogen receptor α and β expression in uterine leiomyomas from premenopausal women. Fertil Steril 2004; 82: 1244–9.
Strissel PL, Swiatek J, Oppelt P, Renner SP, Beckmann MW, Strick R . Transcriptional analysis of steroid hormone receptors in smooth muscle uterine leiomyoma tumors of postmenopausal patients. J Steroid Biochem Mol Biol 2007; 107: 42–7.
Gilbert NE, O'Reilly JE, Chang CJ, Lin YC, Brueggemeier RW . Antiproliferative activity of gossypol and gossypolone on human breast cancer cells. Life Sci 1995; 57: 61–7.
Huang HF, Wang M . Effects of gossypol acetate, danazol, progesterone and GnRH-A on estrogen and progesterone receptors of human endometrial cells. Zhongguo Zhong Xi Yi Jie He Za Zhi 1994; 14: 352–3, 325.
Wang NG, Guan MZ, Li HP, Lei HP . Effect of gossypol acetic acid (GAA) and 15-methyl PGF2 alpha-methyl ester (PG05) on estrogen receptors of rat uteri. Yao Xue Xue Bao 1987; 22: 103–6.
Acknowledgements
This work was supported by a grant from the Shanghai Leading Academic Discipline Project (grant No S30303).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhu, Y., Xie, Sw., Zhang, Jf. et al. Involvement of Bcl-2, Src, and ERα in gossypol-mediated growth inhibition and apoptosis in human uterine leiomyoma and myometrial cells. Acta Pharmacol Sin 31, 1593–1603 (2010). https://doi.org/10.1038/aps.2010.153
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/aps.2010.153
